{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T10:17:11Z","timestamp":1771496231394,"version":"3.50.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Fujifilm Wako Pure Chemical Corporation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Invasive fungal diseases (IFDs) are a major cause of morbidity and mortality in immunocompromised patients. (1\u21923)-\u03b2-D-glucan (BDG) is a fungus-derived biomarker used for IFD diagnosis. We aimed to evaluate the diagnostic performance of a novel rapid colourimetric assay, the \u03b2-glucan single M30 test WAKO (M30), and compare its performance with the conventional turbidimetric \u03b2-glucan test WAKO (GT). We retrospectively analysed plasma samples collected from 1289 patients at Kyoto University Hospital. IFD diagnoses were based on the European Organization for Research and Treatment of Cancer\/Mycoses Study Group criteria, excluding BDG. Forty-one patients had confirmed IFDs (22 with invasive candidiasis, 11 with invasive aspergillosis, 6 with Pneumocystis pneumonia, and 2 with other IFDs). The area under the receiver operating characteristic (AUROC) of the M30 assay was 0.892 (95% confidence interval [CI], 0.836\u20130.949). At an optimal cutoff of 6.7 pg\/ml, its sensitivity was 0.732 (95% CI, 0.571\u20130.858), specificity was 0.990 (95% CI, 0.889\u20130.922), positive predictive value was 0.204 (95% CI, 0.142\u20130.278), and negative predictive value was 0.990 (95% CI, 0.983\u20130.995). For a subset of 537 samples, comparative analysis between M30 and GT was performed. The AUROC for the M30 and GT assays was 0.899 and 0.868, respectively (P\u00a0=\u00a0.285). At a cutoff of 11.0 pg\/ml, the sensitivity was 72.2% for both assays, and the specificity was 93.5% vs. 93.3% (P\u00a0=\u00a01.000). The M30 assay demonstrated comparable diagnostic performance to the GT assay, with a shorter assay time that may facilitate earlier clinical decision-making in patients with suspected IFD.<\/jats:p>","DOI":"10.1093\/mmy\/myaf105","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T13:19:59Z","timestamp":1762435199000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic accuracy of a novel blood (1\u21923)-\u03b2-D-glucan colourimetric assay for invasive fungal diseases: The \u03b2-glucan single M30 test WAKO"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1306-3652","authenticated-orcid":false,"given":"Yasuhiro","family":"Tsuchido","sequence":"first","affiliation":[{"name":"Kyoto University Graduate School of Medicine Department of Clinical Laboratory Medicine, , Kyoto 606-8507 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichiro","family":"Mori","sequence":"additional","affiliation":[{"name":"Kyoto University Hospital Microbiology Laboratory, Department of Clinical Laboratory, , Kyoto 606-8507 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8595-8944","authenticated-orcid":false,"given":"Yasufumi","family":"Matsumura","sequence":"additional","affiliation":[{"name":"Kyoto University Graduate School of Medicine Department of Clinical Laboratory Medicine, , Kyoto 606-8507 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Tsuda","sequence":"additional","affiliation":[{"name":"Kyoto University Graduate School of Medicine Department of Clinical Laboratory Medicine, , Kyoto 606-8507 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8934-0375","authenticated-orcid":false,"given":"Koh","family":"Shinohara","sequence":"additional","affiliation":[{"name":"Kyoto University Graduate School of Medicine Department of Clinical Laboratory Medicine, , Kyoto 606-8507 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7822-3269","authenticated-orcid":false,"given":"Masaki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Kyoto University Graduate School of Medicine Department of Clinical Laboratory Medicine, , Kyoto 606-8507 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8886-6145","authenticated-orcid":false,"given":"Miki","family":"Nagao","sequence":"additional","affiliation":[{"name":"Kyoto University Graduate School of Medicine Department of Clinical Laboratory Medicine, , Kyoto 606-8507 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"2026021904061969100_bib1","doi-asserted-by":"crossref","first-page":"w14281","DOI":"10.4414\/smw.2016.14281","article-title":"Common invasive fungal diseases: An overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia","volume":"146","author":"Schmiedel","year":"2016","journal-title":"Swiss Med Wkly"},{"issue":"8","key":"2026021904061969100_bib2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","article-title":"COVID-19-associated fungal infections","volume":"7","author":"Hoenigl","year":"2022","journal-title":"Nat Microbiol"},{"issue":"9","key":"2026021904061969100_bib3","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: A potential risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"2026021904061969100_bib4","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \u201cmissing 50%\u201d of invasive candidiasis: How nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"Clancy","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2026021904061969100_bib5","doi-asserted-by":"crossref","first-page":"i15","DOI":"10.1093\/jac\/dkq438","article-title":"Detection and investigation of invasive mould disease","volume":"66 Suppl 1","author":"Cuenca-Estrella","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"2026021904061969100_bib6","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2026021904061969100_bib7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s11046-021-00549-x","article-title":"Update on non-culture-based diagnostics for invasive fungal disease","volume":"186","author":"Yan","year":"2021","journal-title":"Mycopathologia"},{"issue":"1","key":"2026021904061969100_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1128\/JCM.05267-11","article-title":"Diagnostic accuracy of serum 1,3-\u03b2-D-glucan for Pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: Systematic review and meta-analysis","volume":"50","author":"Onishi","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"12","key":"2026021904061969100_bib9","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1086\/588295","article-title":"Reappraisal of the serum (1\u21923)-beta-D-glucan assay for the diagnosis of invasive fungal infections\u2014A study based on autopsy cases from 6 years","volume":"46","author":"Obayashi","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"2026021904061969100_bib10","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1093\/cid\/ciaa1943","article-title":"Assessment of the role of 1,3-\u03b2-D-glucan testing for the diagnosis of invasive fungal infections in adults","volume":"72","author":"Lamoth","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2026021904061969100_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1164\/rccm.201906-1185ST","article-title":"Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society Clinical Practice guideline","volume":"200","author":"Hage","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021904061969100_bib12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24 Suppl 1","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"2026021904061969100_bib13","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/jac\/dkw156","article-title":"ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Alanio","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"2026021904061969100_bib14","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciq206","article-title":"\u03b2-D-glucan assay for the diagnosis of invasive fungal infections: A meta-analysis","volume":"52","author":"Karageorgopoulos","year":"2011","journal-title":"Clin Infect Dis."},{"issue":"4","key":"2026021904061969100_bib15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/cid\/cis456","article-title":"(1,3)-\u03b2-D-glucan as a prognostic marker of treatment response in invasive candidiasis","volume":"55","author":"Jaijakul","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2026021904061969100_bib16","doi-asserted-by":"crossref","first-page":"e0129022","DOI":"10.1371\/journal.pone.0129022","article-title":"Correlation between circulating fungal biomarkers and clinical outcome in invasive aspergillosis","volume":"10","author":"Neofytos","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"2026021904061969100_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10156-010-0198-6","article-title":"Clinical viability of Fungitell, a new (1\u21923)-\u03b2-D: -Glucan measurement kit, for diagnosis of invasive fungal infection, and comparison with other kits available in Japan","volume":"17","author":"Yoshida","year":"2011","journal-title":"J Infect Chemother"},{"issue":"9","key":"2026021904061969100_bib18","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/mmy\/myab016","article-title":"Prospective comparison of (1,3)-beta-D-glucan detection using colorimetric and turbidimetric assays for diagnosing invasive fungal disease","volume":"59","author":"Alanio","year":"2021","journal-title":"Med Mycol"},{"issue":"12","key":"2026021904061969100_bib19","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/myc.13170","article-title":"Quantification of 1,3-\u03b2-D-glucan by Wako \u03b2-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study","volume":"63","author":"Cento","year":"2020","journal-title":"Mycoses"},{"issue":"9","key":"2026021904061969100_bib20","doi-asserted-by":"crossref","first-page":"e00464","DOI":"10.1128\/JCM.00464-18","article-title":"Comparative analysis of the Wako \u03b2-glucan test and the Fungitell assay for diagnosis of candidemia and Pneumocystis jirovecii pneumonia","volume":"56","author":"Friedrich","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"2","key":"2026021904061969100_bib21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/myc.13207","article-title":"Clinical evaluation of two different (1,3)-\u00df-D-glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study","volume":"64","author":"Zubkowicz","year":"2021","journal-title":"Mycoses"},{"issue":"6","key":"2026021904061969100_bib22","doi-asserted-by":"crossref","first-page":"e00322","DOI":"10.1128\/JCM.00322-19","article-title":"Beta-D-glucan for diagnosing\u00a0Pneumocystis\u00a0Pneumonia: a Direct Comparison between the Wako \u03b2-Glucan Assay and the Fungitell Assay","volume":"57","author":"Mercier","year":"2019","journal-title":"J Clin Microbiol"},{"issue":"7","key":"2026021904061969100_bib23","doi-asserted-by":"crossref","first-page":"e0236095","DOI":"10.1371\/journal.pone.0236095","article-title":"Comparative performance evaluation of Wako \u03b2-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases","volume":"15","author":"De\u00a0Carolis","year":"2020","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"2026021904061969100_bib24","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: Summary of activities of the Intensive Care Unit Working Group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2026021904061969100_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: Rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur Respir J"},{"issue":"12","key":"2026021904061969100_bib26","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1373\/clinchem.2015.246280","article-title":"STARD 2015: An updated list of essential items for reporting diagnostic accuracy studies","volume":"61","author":"Bossuyt","year":"2015","journal-title":"Clin. Chem."},{"issue":"3","key":"2026021904061969100_bib27","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/jcpt.12809","article-title":"The impact of implementing an antifungal stewardship with monitoring of 1-3, \u03b2-D-glucan values on antifungal consumption and clinical outcomes","volume":"44","author":"Ito-Takeichi","year":"2019","journal-title":"J Clin Pharm Ther"},{"key":"2026021904061969100_bib28","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1080\/13693780802308454","article-title":"Role of (1\u21923)-beta-D-glucan in the diagnosis of invasive aspergillosis","volume":"47 Suppl 1","author":"Marty","year":"2009","journal-title":"Med Mycol"},{"issue":"12","key":"2026021904061969100_bib29","doi-asserted-by":"crossref","first-page":"ofy296","DOI":"10.1093\/ofid\/ofy296","article-title":"Serum 1,3-beta-D-glucan values during and after laparoscopic and open intestinal surgery","volume":"5","author":"Szyszkowitz","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"2026021904061969100_bib30","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1086\/588563","article-title":"Pseudomonas aeruginosa as a cause of 1,3-beta-D-glucan assay reactivity","volume":"46","author":"Mennink-Kersten","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2026021904061969100_bib31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jinf.2010.08.005","article-title":"Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: A multicenter trial in Japan","volume":"61","author":"Kohno","year":"2010","journal-title":"J. Infect."},{"issue":"3","key":"2026021904061969100_bib32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jiac.2013.10.016","article-title":"Pathogenesis and clinical features of chronic pulmonary aspergillosis\u2014Is it possible to distinguish CNPA and CCPA clinically?","volume":"20","author":"Izumikawa","year":"2014","journal-title":"J Infect Chemother"},{"issue":"1","key":"2026021904061969100_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/mmy\/myaa028","article-title":"Performance characteristics of Fungitell STAT\u2122, a rapid (1\u21923)-\u03b2-D-glucan single patient sample in vitro diagnostic assay","volume":"59","author":"D\u2019Ordine","year":"2021","journal-title":"Med Mycol"},{"issue":"7","key":"2026021904061969100_bib34","doi-asserted-by":"crossref","first-page":"myaf050","DOI":"10.1093\/mmy\/myaf050","article-title":"Performance of Fungitell STAT point-of-care test for the diagnosis of invasive fungal diseases","volume":"63","author":"Cordier","year":"2025","journal-title":"Med Mycol"},{"issue":"11","key":"2026021904061969100_bib35","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.282.11.1061","article-title":"Empirical evidence of design-related bias in studies of diagnostic tests","volume":"282","author":"Lijmer","year":"1999","journal-title":"JAMA"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myaf105\/65253000\/myaf105.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/11\/myaf105\/65253000\/myaf105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/11\/myaf105\/65253000\/myaf105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:06:33Z","timestamp":1771491993000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myaf105\/8317944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,4]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myaf105","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,11]]},"article-number":"myaf105"}}